Treatment with captopril abrogates the altered expression of alpha1 macroglobulin and alpha1 antiproteinase in sera of spontaneously hypertensive rats

被引:3
作者
Aminudin, Norhaniza [1 ,2 ]
Abdullah, Nur-Atiqah H. [1 ]
Misbah, Hasni [3 ]
Karsani, Saiful A. [1 ,2 ]
Husain, Ruby [4 ]
Hoe, See Z. [4 ]
Hashim, Onn H. [2 ,3 ]
机构
[1] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Ctr Prote Res, Kuala Lumpur 50603, Malaysia
[3] Univ Malaya, Dept Mol Med, Fac Med, Kuala Lumpur 50603, Malaysia
[4] Univ Malaya, Dept Physiol, Fac Med, Kuala Lumpur 50603, Malaysia
来源
PROTEOME SCIENCE | 2012年 / 10卷
关键词
hypertension; biomarker; spontaneously hypertensive rats; serum proteins; proteomics; RETINOL-BINDING PROTEIN-4; TONIN; INHIBITOR;
D O I
10.1186/1477-5956-10-17
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Proteins that are associated with hypertension may be identified by comparing the 2-dimensional gel electrophoresis (2-DE) profiles of the sera of spontaneously hypertensive rats (SHR) with those generated from normotensive Spraque-Dawley rats (SDR). Results: Five proteins of high abundance were found to be significantly altered when the 2-DE serum profiles of the SHR were compared to those that were similarly generated from the SDR. Analysis by mass spectrometry and database search identified the proteins as retinol binding protein 4, complement C3, albumin (19.9 kDa fragment), alpha1 macroglobulin and alpha1 antiproteinase, which are all known to be associated with hypertension. The altered expression of the two latter proteins was found to be abrogated when similar analysis was performed on sera of the SHR that were treated with captopril. Conclusion: Our data suggests that serum alpha1 macroglobulin and alpha1 antiproteinase are potentially useful complementary biomolecular indicators for monitoring of hypertension.
引用
收藏
页数:7
相关论文
共 24 条
  • [1] Benjamini Y, 1995, J ROY STAT SOC, V57, P289
  • [2] Is hypertension an inflammatory process?
    Boos, Christopher J.
    Lip, Gregory Y. H.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (13) : 1623 - 1635
  • [3] PLASMA-PROTEIN CHANGES IN PRIMARY HYPERTENSION IN HUMANS AND RATS
    CLOIX, JF
    DEVYNCK, MA
    BRENTANO, JLF
    MEYER, P
    [J]. HYPERTENSION, 1983, 5 (01) : 128 - 134
  • [4] MYOCARDIAL FIBROSIS AND STIFFNESS WITH HYPERTROPHY AND HEART-FAILURE IN THE SPONTANEOUSLY HYPERTENSIVE RAT
    CONRAD, CH
    BROOKS, WW
    HAYES, JA
    SEN, S
    ROBINSON, KG
    BING, OHL
    [J]. CIRCULATION, 1995, 91 (01) : 161 - 170
  • [5] Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors
    Doustjalali, SR
    Yusof, R
    Yip, CH
    Looi, LM
    Pillay, B
    Hashim, OH
    [J]. ELECTROPHORESIS, 2004, 25 (14) : 2392 - 2401
  • [6] Fatality of acute coronary events in relation to hypertension and low-grade inflammation:: a population-based cohort study
    Engstrom, G.
    Hedblad, B.
    Janzon, L.
    Lindgarde, F.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2006, 20 (08) : 581 - 586
  • [7] Serpin structure, mechanism, and function
    Gettins, PGW
    [J]. CHEMICAL REVIEWS, 2002, 102 (12) : 4751 - 4803
  • [8] IMPROVED SILVER STAINING PROCEDURE FOR FAST STAINING IN PHASTSYSTEM DEVELOPMENT UNIT .1. STAINING OF SODIUM DODECYL-SULFATE GELS
    HEUKESHOVEN, J
    DERNICK, R
    [J]. ELECTROPHORESIS, 1988, 9 (01) : 28 - 32
  • [9] Serum albumin and blood pressure: a population-based, cross-sectional study
    Hostmark, AT
    Tomten, SE
    Berg, JE
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 (04) : 725 - 730
  • [10] KININOGENASE ACTIVITY OF TONIN
    IKEDA, M
    ARAKAWA, K
    [J]. HYPERTENSION, 1984, 6 (02) : 222 - 228